Ropinirole, a New ALS Drug Candidate Developed Using iPSCs - ScienceDirect
Ropinirole, a New ALS Drug Candidate Developed Using iPSCs: Trends in Pharmacological Sciences
FTD and ALS—translating mouse studies into clinical trials | Nature Reviews Neurology
Frontiers | Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial - eBioMedicine
ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? | Semantic Scholar
ALS Phase 3 Trial to Test Alexion's Complement System Inhibitor Ultomiris
Gene therapy for ALS: A review: Molecular Therapy
The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials - YouTube
Amyotrophic Lateral Sclerosis (Chapter 24) - Clinical Trials in Neurology
Frontiers | ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
List of drugs and compounds tested in human ALS clinical trials. | Download Table
New Eligibility Criteria Needed to Improve ALS Trial Outcome, Study Says
Top 10 ALS Clinical Trials [2022 Studies] | Power
ALS clinical trials: How stem cells could fuel biomarker development